Citius Pharmaceuticals Inc (CTXR) 0.6400 $CTXR Citius

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Citius Pharmaceuticals Inc (CTXR) 0.6400 $CTXR

Citius Pharmaceuticals to Present at the 2016 Aegis Growth Conference
PR Newswire - Mon Sep 19, 6:00AM CDT
Citius Pharmaceuticals, Inc. ("Citius" (OTC BB: CTXR), a specialty pharmaceutical company dedicated to developing and commercializing adjunctive cancer care and critical care drug products, announced today that its President and CEO, Myron Holubiak, will present at the 2016 Aegis Growth Conference. The Conference will be held on September 20-22, 2016 at the Encore at Wynn Las Vegas.

Citius Initiates Mino-Lok(TM) Phase 3 Trial
PR Newswire - Tue Sep 13, 6:00AM CDT
Citius Pharmaceuticals, Inc. ("Citius" (OTC BB: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that it has initiated the pivotal Phase 3 clinical trial Mino-Lok(TM), an antibiotic lock solution used to salvage infected central venous catheters (CVCs) and to treat catheter related bloodstream infections (CRBSIs).
MEDP: 30.44 (-0.13)

Citius Pharmaceuticals, Inc., Initiates Manufacturing of Mino-Lok(TM)
PR Newswire - Thu Sep 08, 6:00AM CDT
Citius Pharmaceuticals, Inc. ("Citius" (OTC QB: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that it has initiated manufacturing for the company's clinical trial of Mino-Lok (TM), an antibiotic lock solution used to salvage central venous catheters (CVCs) and to treat catheter related bloodstream infections (CRBSIs).

Citius Pharmaceuticals to Present at the Rodman & Renshaw 18th Annual Global Investment Conference
PR Newswire - Wed Sep 07, 9:32AM CDT
Citius Pharmaceuticals, Inc. ("Citius" (OTC QB: CTXR), a specialty pharmaceutical company dedicated to developing and commercializing adjunctive cancer care and critical care drug products, announced today that its Chairman, Len Mazur, will present at the Rodman & Renshaw 18th Annual Global Investment Conference. The Conference will be held on September 11-13, 2016 at the Lotte New York Palace Hotel, New York City.

Citius Announces Completion of In-Depth Interviews on Patient-Reported Outcomes: Signs and Symptoms of Hemorrhoids and Treatments
CNW Group - Tue Aug 23, 12:55PM CDT
Leading Life Sciences Market Research Firm Conducted Patient Interviews

Looking for "Firsts" in Health Care? Check Out Upcoming Catalysts for Citius Pharmaceuticals
PR Newswire - Thu Aug 04, 9:13AM CDT
By Sara Bowman, Senior Staff Writer, Online Media Group, Inc.

Citius Pharmaceuticals Provides Shareholder Update on Recent Achievements
PR Newswire - Mon Aug 01, 6:00AM CDT
Citius Pharmaceuticals, Inc. ("Citius" (OTC BB: CTXR), a specialty pharmaceutical company dedicated to developing and commercializing adjunctive cancer care and critical care drug products, today provided shareholders with an update regarding the company's recent more notable achievements.

OTCQX and OTCQB Companies to Present at 2016 Marcum MicroCap Conference
PR Newswire - Tue May 31, 5:49PM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lineup of OTCQX® Best and OTCQB® Venture Market companies presenting at the Marcum MicroCap Conference, taking place June 1-2nd at the Grand Hyatt New York. The Marcum MicroCap Conference, is dedicated to providing a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The Conference will feature presentations by CEOs and CFOs from various industry sectors, expert panels, and the opportunity to meet with management of presenting companies on a one-on-one basis.
LTEA: 4.90 (-0.10)

Citius Pharmaceuticals Announces Results from Phase 2a Trial of Hydrocortisone and Lidocaine Combination Cream in Patients with Grade I and II Hemorrhoids
PR Newswire - Mon Feb 01, 6:00AM CST
Citius Pharmaceuticals, Inc. (OTCQB: CTXR) today announced top line data from the first Phase 2a clinical trial of hydrocortisone acetate (HC) and lidocaine hydrochloride (L) as single agents and in combination (HC+L) in patients with grade I and II hemorrhoids. Citius' hydrocortisone and lidocaine cream is targeting to become the first FDA -approved prescription product to treat hemorrhoids in the U.S.

Citius Pharmaceuticals, Inc. Announces Appointment of Mr. Suren Dutia to Its Board of Directors
PR Newswire - Thu Oct 08, 6:00AM CDT
Citius Pharmaceuticals, Inc. (OTCQB: CTXR), (the "Company" announced today that it has appointed Mr. Suren Dutia to the board of directors effective October 8, 2015.

Citius Pharmaceuticals Announces Myron Holubiak, Former President of Roche Laboratories, Inc., USA, has Joined Its Board of Directors
PR Newswire - Tue Oct 06, 6:00AM CDT
Citius Pharmaceuticals, Inc. (OTCQB: CTXR), (the "Company" announced today that it has appointed Mr. Myron Holubiak to the board of directors effective October 1, 2015.
BIOS: 2.87 (-0.05), ASMB: 7.32 (+0.16)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Supply Maverick Simplifies Global Shipping Processes

Updated Category News Views 4

Paving the Way for Seamless International Shipping Supply Maverick's got a new mantra, folks: simplicity. They're slicing through the mess of international shipping and bringing some much-needed clarity for customers in Canada, Australia, and New Zealand. It’s about time someone shook up the logistics playbook. The Nuts and Bolts of the New Shipping System Imagine being...

Continue Reading
World Fire Congress 2026 Champions Global Fire Safety

Updated Category News Views 8

Rethinking Fire Safety with a Global Mindset The 2026 World Fire Congress wrapped up in London, signaling a big shift in how we tackle fire safety. Over 60 nations were represented, and they all walked away singing the same tune: if we’re going to handle these ever-mounting fire risks, we have to lean on each other a lot more. Next stop on this crusade? The flashy city...

Continue Reading
QuickFi Nabs Top Finovate Award for Fourth Time

Updated Category News Views 4

An Unstoppable Force in Fintech Well, if QuickFi hasn't made a name for itself in fintech, then folks, I don't know what to tell you. This year, they’ve snagged yet another prestigious Finovate Award—this time for Best SMB/SME Banking Solution. That's not their first rodeo either; it’s the fourth time they’ve walked away winners. It's almost like they're...

Continue Reading
2026 Buy-Side Index Reveals State Market Variance

Updated Category News Views 5

Toss out your one-size-fits-all real estate predictions; the Q2 2026 Buy-Side Index just unveiled some real whoppers about the housing market. What we're seeing isn't your typical year-over-year growth across the board. Nope, we're seeing splits as sharp as a knife between states. Some places are shooting up in price, while others seem to be stuck in mud. Price Surges and...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
DCM Services Teams with AKUVO to Boost Estate Recoveries

Updated Category News Views 6

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Continue Reading
Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 6

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading
XKL Delivers MediaLight for High-Speed Optical Transport

Updated Category News Views 5

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Continue Reading
Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 7

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 4

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading

Top 5 Most Recently Viewed Articles

ScImage Welcomes Don Fowler as COO to Enhance Growth Strategy

Updated Category News Views 183

ScImage Enhances Leadership with the Appointment of Don Fowler ScImage, Inc. has recently taken significant steps to bolster its leadership team by appointing Don Fowler as Chief Operating Officer. With an impressive background spanning over three decades in the medical imaging industry, particularly at Toshiba America Medical Systems and Siemens Healthcare, Fowler brings...

Continue Reading
West Pharmaceutical Reports Strong Q3 Results and Outlook

Updated Category News Views 42

Strong Q3 Performance of West Pharmaceutical Services West Pharmaceutical Services, Inc. recently shared its third-quarter performance, demonstrating robust demand for its syringe and injectable pharmaceutical packaging solutions. With an adjusted EPS of $1.85, the company slightly fell from the previous year’s figure of $2.16, surpassing market expectations of $1.50....

Continue Reading
Parents Champion Meta's Online Safety Agreement

Updated Category News Views 10

Any old-timer in the market game will tell you this: safeguarding the next generation runs deeper than just chasing profits. A recent poll by the Coalition to Empower our Future reveals something that ain’t too surprising if you’ve been paying attention. Parents all over the nation are nodding along to Meta’s new move to bolster online protections for younger folks....

Continue Reading
European Wax Center, Inc. Sees Growth Amid Operational Changes

Updated Category News Views 246

European Wax Center Reports Fiscal Second Quarter Results European Wax Center, Inc. (NASDAQ: EWCZ), a leading provider of out-of-home waxing services, recently announced its financial performance, showcasing the remarkable resilience of its brand and operational strategies. The franchise, with 1,059 centers across 44 states, demonstrated a commitment to growth and...

Continue Reading
Fusion Fuel Green Collaborates with Alien Fuel for Project

Updated Category News Views 151

Fusion Fuel Green PLC Enters Joint Venture with Alien Fuel Fusion Fuel Green PLC (Nasdaq: HTOO) recently announced a significant milestone in its journey towards sustainable energy solutions. The company has signed a Joint Venture Agreement with Alien Fuel, marking the establishment of a new entity, Biosteam Energy, aimed at pioneering the Fairfield Industrial...

Continue Reading